European Union Drugs Agency. (2025) Viral hepatitis elimination barometer among people who inject drugs in Europe.
Preview | Title | Contact |
---|---|---|
|
PDF (Viral hepatitis elimination barometer - PDF of webpage July 2025)
1MB | |
|
PDF (Viral hepatitis elimination barometer - PDF of webpage July 2024)
1MB |
External website: https://www.euda.europa.eu/publications/data-facts...
The elimination barometer for hepatitis B and C among people who inject drugs is designed to support countries affiliated to the EU Drugs Agency (EUDA, formerly EMCDDA) in monitoring their progress towards the Sustainable Development Goal 3.3 and the elimination of viral hepatitis as a major public health threat by 2030. Under five building blocks, it brings together 11 epidemiological indicators (2022 or latest) and corresponding 2025 targets related to people who inject drugs for the EU, Norway and Türkiye, following the WHO monitoring frameworks (WHO, 2016b, 2017, 2021).
For each indicator, the EUDA elimination barometer provides:
- Contextual information, references and definitions
- An infographic showing national data
- The related 2025 WHO target
- An achievement status: how many countries have reached the target
- The corresponding data tables
Monitoring and evaluation framework: indicators to monitor and evaluate the health sector response to viral hepatitis B and C among people who inject drugs
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > Hepatitis C (HCV)
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
J Health care, prevention, harm reduction and treatment > Health care delivery
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page